Active/Completed Active GrantsCompleted Grants PI Name Sort descending PI Organization Title Grant Number Program Official Rowland, Kendrith Martin Carle Foundation United States Carle Cancer Center NCI Community Oncology Research Program (NCORP) 3UG1CA189861-11S1 Vanessa A. White, M.P.H. Salman, Emad Florida Assn Of Pediatric Tumor Prog United States The Florida Pediatric NCORP: NCI Community Oncology Research Program. 3UG1CA189973-11S1 Vanessa A. White, M.P.H. Salman, Emad Florida Assn Of Pediatric Tumor Prog United States The Florida Pediatric NCORP: NCI Community Oncology Research Program. 3UG1CA189973-11S1 Vanessa A. White, M.P.H. Salvemini, Daniela Saint Louis University United States Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-04 Rachel Altshuler, Ph.D. Salvemini, Daniela Saint Louis University United States Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-04 Rachel Altshuler, Ph.D. Sands, Stephen Alan Sloan-Kettering Inst Can Research United States Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D. Sands, Stephen Alan Sloan-Kettering Inst Can Research United States Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D. Sands, Stephen Alan Sloan-Kettering Inst Can Research United States Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D. Santomasso, Bianca Denise Sloan-Kettering Inst Can Research United States Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy 5R01CA293922-02 Monica Epstein, B.S.N., RN, OCN Santomasso, Bianca Denise Sloan-Kettering Inst Can Research United States Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy 5R01CA293922-02 Monica Epstein, B.S.N., RN, OCN Santos-Reyes, Luis Javier Comprehensive Cancer Center/ Univ/Pr United States Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP) 3UG1CA189862-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H. Santos-Reyes, Luis Javier Comprehensive Cancer Center/ Univ/Pr United States Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP) 3UG1CA189862-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H. Saphner, Thomas J Aurora Health Care, Inc. United States Aurora NCORP Community Site 3UG1CA190140-11S1 Vanessa A. White, M.P.H. Saphner, Thomas J Aurora Health Care, Inc. United States Aurora NCORP Community Site 3UG1CA190140-11S1 Vanessa A. White, M.P.H. Schallenkamp, John M. Montana Cancer Consortium United States Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming 3UG1CA189872-11S1 Vanessa A. White, M.P.H. Pagination « First First page ‹ Previous Previous page … 20 21 22 23 … Next › Next page Last » Last page